He Qiqi, Babcook Melissa A, Shukla Sanjeev, Shankar Eswar, Wang Zhiping, Liu Guiming, Erokwu Bernadette O, Flask Chris A, Lu Lan, Daneshgari Firouz, MacLennan Gregory T, Gupta Sanjay
Department of Urology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio.
Department of Urology, Key Laboratory of Disease of Urological Systems, Gansu Nephro-Urological Clinical Center, Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
Prostate. 2016 Aug;76(11):964-76. doi: 10.1002/pros.23185. Epub 2016 Apr 4.
Accumulating evidences suggests that obesity and metabolic syndrome (MetS) contribute towards lower urinary tract symptoms (LUTS) through alterations in the phenotype of bladder and prostate gland. Clinical studies indicate a link between MetS and LUTS. Nevertheless, there is lack of suitable animal model(s) which could illustrate an association linking obesity to LUTS. We examined the lower urinary tract function in an obesity-initiated MetS mouse model.
Male C57BL/6N wild-type and obese B6.V-Lepob/J maintained on regular diet for 28 weeks were subjected to the assessment of body weight (BW), body length (BL), waist circumference (WC), body mass index (BMI), blood glucose (BG), plasma insulin (INS), plasma leptin (LEP), total cholesterol (CHO), free fatty acid (FFA), and measurement of urinary functions. Whole animal peritoneal and subcutaneous adipose tissue measurements as well as prostate and bladder volumes were analyzed by MRI followed by histological evaluation. These parameters were used to draw correlations between MetS and LUTS.
Obesity parameters such as BW, WC, and BMI were significantly higher in B6.V-Lepob/J mice compared to C57BL/6N mice (P < 0.01). Higher levels of total CHO and FFA were noted in B6.V-Lepob/J mice than C57BL/6N mice (P < 0.05). These results were concurrent with frequency, lower average urine volume and other urinary voiding dysfunctions in B6.V-Lepob/J mice. MRI assessments demonstrate marked increase in body fat and prostate volume in these mice. Compared to C57BL/6N mice, histological analysis of the prostate from B6.V-Lepob/J mice showed increased proliferation, gland crowding, and infiltration of immune cells in the stroma; whereas the bladder urothelium was slightly thicker and appears more proliferative in these mice. The regression and correlation analysis indicate that peritoneal fat (R = 0.853; P < 0.02), CHO (R = 0.729; P < 0.001), BG (R = 0.712; P < 0.001) and prostate volume (R = 0.706; P < 0.023) strongly correlate with LUTS whereas BMI, WC, INS, and FFA moderately correlate with the prevalence of bladder dysfunction.
Our results suggest that LUTS may be attributable in part to obesity and MetS. Validation of an in vivo model may lead to understand the underlying pathophysiological mechanisms of obesity-related LUTS in humans. Prostate 76:964-976, 2016. © 2016 Wiley Periodicals, Inc.
越来越多的证据表明,肥胖和代谢综合征(MetS)通过膀胱和前列腺表型的改变导致下尿路症状(LUTS)。临床研究表明MetS与LUTS之间存在联系。然而,缺乏合适的动物模型来说明肥胖与LUTS之间的关联。我们在一个由肥胖引发的MetS小鼠模型中研究了下尿路功能。
将雄性C57BL/6N野生型小鼠和肥胖的B6.V-Lepob/J小鼠维持常规饮食28周,然后对体重(BW)、体长(BL)、腰围(WC)、体重指数(BMI)、血糖(BG)、血浆胰岛素(INS)、血浆瘦素(LEP)、总胆固醇(CHO)、游离脂肪酸(FFA)进行评估,并测量排尿功能。通过磁共振成像(MRI)分析整个动物的腹膜和皮下脂肪组织测量值以及前列腺和膀胱体积,随后进行组织学评估。这些参数用于绘制MetS与LUTS之间的相关性。
与C57BL/6N小鼠相比,B6.V-Lepob/J小鼠的肥胖参数如BW、WC和BMI显著更高(P < 0.01)。B6.V-Lepob/J小鼠的总CHO和FFA水平高于C57BL/6N小鼠(P < 0.05)。这些结果与B6.V-Lepob/J小鼠的尿频、平均尿量降低及其他排尿功能障碍同时出现。MRI评估显示这些小鼠的体脂和前列腺体积显著增加。与C57BL/6N小鼠相比,对B6.V-Lepob/J小鼠前列腺的组织学分析显示,其增殖增加、腺体拥挤以及基质中免疫细胞浸润;而这些小鼠的膀胱尿路上皮稍厚且增殖更明显。回归和相关性分析表明,腹膜脂肪(R = 0.853;P < 0.02)、CHO(R = 0.729;P < 0.001)、BG(R = 0.712;P < 0.001)和前列腺体积(R = 0.706;P < 0.023)与LUTS密切相关,而BMI、WC、INS和FFA与膀胱功能障碍的患病率中度相关。
我们的结果表明,LUTS可能部分归因于肥胖和MetS。对体内模型的验证可能有助于了解人类肥胖相关LUTS的潜在病理生理机制。《前列腺》76:964 - 976,2016年。©2016威利期刊公司。